Working… Menu
Trial record 42 of 178 for:    LENALIDOMIDE AND Leukemia

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01446133
Recruitment Status : Active, not recruiting
First Posted : October 5, 2011
Last Update Posted : May 10, 2019
Celgene Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center